Terns Pharmaceuticals
TERN
TERN
156 hedge funds and large institutions have $663M invested in Terns Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 53 funds opening new positions, 53 increasing their positions, 37 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
24% more funds holding
Funds holding: 126 → 156 (+30)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
7.24% less ownership
Funds ownership: 101.4% → 94.16% (-7.2%)
Holders
156
Holding in Top 10
3
Calls
$8.73M
Puts
$4.45M
Top Buyers
| 1 | +$18.2M | |
| 2 | +$17.6M | |
| 3 | +$13.6M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$11.9M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$10.5M |
Top Sellers
| 1 | -$13.1M | |
| 2 | -$9.29M | |
| 3 | -$7.83M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$7.65M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$6.64M |